HIGHLIGHTS FROM PROBIOTA 2017 IN BERLIN

Probiota Insights: What have the last five years taught us about probiotics?

Loading the player...

There has been a revolution in technology. But what do we now know about probiotics that we didn’t know five years ago?

The recent Probiota event in Berlin brought together leading experts in research and business to discuss the state of play in probiotics, prebiotics and microbiome modification.

NutraIngredients asked for expert insights on a range of topics. Here we questioned what the last five years has taught us about probiotics.

“It’s like comparing the dial up telephone to my smartphone. We’ve come that far in five years with the knowledge and understanding (…) and we’re really at the leading edge, we’re really still at the start,” said Peter Lagan, a consultant who works on product development in New Zealand.  

Indeed, Isabelle Champie from Lallemand noted that modern research has revealed that the microbiome has an impact on the whole body, while Susanna Baekgaard of Bifodan told us that new computer technologies will help the industry understand the emerging connections between the microbiome and the skin, the mouth, and women’s health.

Meanwhile, Jonathan Krive from Asia Microbiota Bank said the advent of next generation metagenomic sequencing, researchers and the industry can begin to look beyond correlations, and even cause and effect relationships – and start to explore mechanisms of action.

Related News

Probiota Insights: Is a probiotic EFSA claim possible?

Probiota Insights: Is a probiotic EFSA claim possible?

Probiota Insights: Which probiotic formats hold the most exciting future potential?

Probiota Insights: Which probiotic formats hold the most exciting future potential?

Can prebiotics rival drugs for exercise-induced asthma?

Can prebiotics rival drugs for exercise-induced asthma?

Results from large scale clinical studies in dentistry appear promising, but clinical recommendations are still premature. ©iStock/VladimirFLoyd

All mouth and some action: Oral probiotics still in infancy but promise is there

The best known example of faecal microbial transplant (FMT) is the treatment of clostridium difficile infections. ©iStock/igorr1

Making a deposit: Faecal biobanks have ‘great potential’

The use of probiotics in premature infants was associated with a decreased incidence of NEC, late-onset sepsis, and mortality. ©iStock

A 'golden age' of probiotics for premature babies? It depends on birth weight and strains: Meta-analysis

Probiota Insights: Does the prebiotic definition need reworking?

Probiota Insights: Does the prebiotic definition need reworking?

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.